The United Nations Office at Geneva
Multimedia Newsroom
COVID-19: UN health agency issues conditional advice against using remdesivir
Patients with COVID-19 should not be given the antiviral drug remdesivir “regardless of disease severity”, the UN World Health Organization (WHO) said on Friday.
Nonetheless, describing its recommendation as “conditional”, as opposed to “strong”, WHO stressed that data from a global trial on the efficacy of remdesivir was inconclusive, and that further trials should continue into its use for more vulnerable patients.
“We recommend a conditional recommendation – I want to highlight that - against the use of remdesivir in hospitalised patients with COVID-19 regardless of disease severity,” said Dr Janet Diaz, Head of Clinical Care at WHO, during a virtual press conference in Geneva.
According to data from the WHO-led Solidarity trial which was then examined by a panel of international experts behind the recommendation, “possibly remdesivir can lead to 29 fewer deaths per 1,000 patients or up to 11 more deaths per 1000 patients”, Dr Diaz said. “So you can see that …the confidence interval are relatively large…there was no evidence that there was any important effect on mortality, on the need for mechanical ventilation or the time to clinical improvement.”
But this did “not prove” that the antiviral “had no benefit at all”, Dr Diaz insisted. “There could still be potential small benefit, maybe in a health sub-group which is why the panel also recommended continued trials, continued enrolment into clinical trials.”
The WHO official explained that this might be “severe patients versus critical patients” or whether the antiviral is used “early versus late”.
Dr Bram Rochwerg, who was among the experts advising WHO, noted that there would likely be regional “variations” in the use of remdesivir.
While a minority of people will still choose to use it, the majority would not, based on the available data, he said.
“There may be groups (who might benefit) and the data was a bit more of a close call, so that’s why we felt strongly that trials need to continue using remdesivir and studying remdesivir and looking to see if there are specific groups that might, that might benefit,” he said. “We were very explicit that we do believe that these studies need to continue (and) Solidarity is continuing.”
Although the remdesivir development mirrors similar attempts to use other antivirals against the new coronavirus, Dr Diaz said there was no reason to lose hope in the fight against COVID-19.
“I do think there is a tremendous global effort to investigate treatments. You know, I think a lot of interest was done upfront with the repurposed of drugs, repurposed antivirals, you know we saw that with other repurposed drugs such as hydroxychloroquine, lopinavir, and there was a big push to try to test these and they’ve been tested and unfortunately, we just haven’t, you know, the results haven’t been as promising as we had hoped. But I don’t want to forget that we do have one lifesaving drug and even though it’s a repurposed old, old drug dexamethasone, a corticosteroid, we do know that that does reduce mortality, save lives of patient with severe and critical so there is something.”
Latest data from WHO indicates that eight in 10 people infected with COVID report mild symptoms, Dr Diaz said.
“Since the beginning (of the pandemic)…about 80 per cent of people have, you know, mild disease, a proportion maybe moderate disease and then only a small proportion, a smaller proportion, 20 per cent go on to develop severe or critical disease, and critical disease is a small, small portion, it’s five per cent or less, and that is…and that seems to be kind of consistent I think through the literature so most patients do have, if they have mild disease, self-limiting disease, they get better on their own, their immune system kicks in and they get better.”
Nonetheless, there are reports of more “persistent longer-term symptoms”, Dr Diaz noted. “So even though they don’t get severe disease there can be some persistent symptoms that lasts longer than one would have hoped for.”
- SOUNDBITE (English) — Dr Janet Diaz, Head of Clinical Care, WHO: “We recommend a conditional recommendation - so I want to highlight that, it’s a conditional recommendation - against the use of remdesivir in hospitalized patients - with COVID-19, regardless of disease severity.”
- SOUNDBITE (English) — Dr Janet Diaz, Head of Clinical Care, WHO: “Possibly remdesivir can lead to 29 fewer deaths par 1,000 patients or up to 11 more deaths per 1,000 patients so you can see that this is, the confidence interval is a little bit large.”
- SOUNDBITE (English) — Dr Janet Diaz, Head of Clinical Care, WHO: “It was not clear that, there was no evidence, that there was any important effect on mortality, on the need for mechanic ventilation or the time to clinical improvement.”
- SOUNDBITE (English) — Dr Janet Diaz, Head of Clinical Care, WHO: “This did not prove that remdesivir does not have a benefit at all and that’s why it is a conditional recommendation, there can still be potential small benefit, maybe in a health sub-group, which is why the panel also recommended continued trials, continued enrolment into clinical trials.”
- SOUNDBITE (English) — Dr Janet Diaz, Head of Clinical Care, WHO: “You know, is there a sub-group that may benefit more – such as severe patients versus critical patients. Is there a timing in disease that may benefit more - such as early versus late - and those are all considerations that are in the guidelines.”
- SOUNDBITE (English) — Dr Bram Rochwerg, practising ITU clinician and expert adviser for WHO-led Solidarity Trial: “There may be groups and the data was a bit more of a close call, so that’s why we felt strongly that trials need to continue using remdesivir and studying remdesivir and looking to see if there are specific groups that might, that might benefit. And as she said, we were very explicit that we do believe that these studies need to continue, Solidarity is continuing, so.”
- SOUNDBITE (English) — Dr Janet Diaz, Head of Clinical Care, WHO: “I do think there is a tremendous global effort to investigate treatments. You know, I think a lot of interest was done upfront with the repurposed of drugs, repurposed antivirals, you know we saw that with other repurposed drugs such as hydroxychloroquine, lopinavir, and there was a big push to try to test these and they’ve been tested and unfortunately, we just haven’t, you know, the results haven’t been as promising as we had hoped. But I don’t want to, I don’t want to forget that we do have one lifesaving drug and even though it’s a repurposed old, old drug dexamethasone, a corticosteroid, we do know that that does reduce mortality, save lives of patient with severe and critical so there is something.”
- SOUNDBITE (English) — Dr Janet Diaz, Head of Clinical Care, WHO: “Since the beginning, is that about 80 per cent of people have, you know, mild disease, a proportion maybe moderate disease and then only a small proportion, a smaller proportion, 20 per cent go on to develop severe or critical disease, and critical disease is a small, small portion, it’s five per cent or less, and that is…and that seems to be kind of consistent I think through the literature so most patients do have, if they have mild disease, self-limiting disease, they get better on their own, their immune system kicks in and they get better.”
- SOUNDBITE (English) — Dr Janet Diaz, Head of Clinical Care, WHO: “We do know that even patients with mild disease may have persistent longer-term symptoms. And that has been now described; so even though they don’t get severe disease there can be some persistent symptoms that lasts longer than one would have hoped for.”
Similar Stories
1
1
1
Edited News | UNHCR
Displacement on the rise in Yemen as fighting continues - UNHCR
As hostilities worsen in Yemen, more people have been fleeing their homes, further intensifying the humanitarian crisis within the region, the UN Refugee Agency (UNHCR) warned on Tuesday.
1
1
1
Edited News | IOM , OHCHR , UNFPA , UNOG , UNHCR , WHO
Yemen’s humanitarian crisis growing by the hour amid spike in displacement
Yemenis displaced by renewed fighting have described fleeing for their lives amid shelling and gunfire, aid agencies reported on Friday, while highlighting the dramatic increase in humanitarian needs in the country and in Djibouti, where thousands have sought shelter.
1
1
1
Edited News | OHCHR , UNOG
The UN Human Rights Office issued on Friday a report documenting a shocking pattern of sexual violence amid Russia’s full-scale armed attack on Ukraine.
2
1
2
Edited News , Press Conferences | WMO
As world’s water reserves change, countries must prepare for a new reality: WMO
New data showing that rivers were at their lowest level for decades last year provides further evidence that the climate crisis is real and countries must act immediately to protect themselves from the increasing threat to communities and livelihoods, the UN World Meteorological Organization (WMO) said on Thursday.
The key findings from WMO’s State of Global Water Resources 2025 report covering the hydrological cycle and extreme events in the five-year period to last year:
- 2025 was one of driest years for river discharge in 35 years
- Past seven years have seen abnorfmal river flows
- Water storage on Earth’s land surface has decreased in past decade
- Widespread glacier loss across all regions for fourth consecutive year
- Asia and Africa are regions most affected by water-related disasters
- Water data availability has improved, but gaps remain in hard-hit areas
Highlighting the long-term decline in the Earth’s freshwater storage and glacier melt, WMO Secretary-General Celeste Saulo explained that the planet’s water reserves used to act as a planetary “savings account” that absorbed the occasional dry season, avoiding a water crisis. “One of the central stories of the 2025 report is what is happening to that savings account? And the simple answer is that we are depleting it,” she told journalists in Geneva.
Groundwater reserves are equally stretched and have been in decline since 2014, WMO’s report states, with nearly two-thirds of monitored wells worldwide showing levels lower than the historical norm and indicating a shift “further toward deficit…not recovery”.
“At the same time, we are seeing more water-related disasters,” Ms. Saulo said, while also stressing that the currently strengthening El Niño “will increase the risk of drought in some areas, and flooding in others”.
Glaciers disappearing
In 2025, for the fourth consecutive year, every major glaciated region on Earth lost ice mass, leading to short-term hazards including floods and long-term water insecurity, according to WMO.
Responding to a question about whether the changing global water cycle might have contributed to the deadly Nepal-China flooding disaster, Ms. Saulo explained that melting ice and rock was just one factor in the chain of events that ultimately sent a massive and deadly wall of water and debris downstream on 26 August, killing at least 1,367 people.
“You asked if it could happen again? Absolutely; the problem in this region is that there’s 63,700 glaciers at the last count,” she told a Press Conference in Geneva. “Even if you’re looking with remote sensing with satellites at these glaciers, you might see some faults, you might see some slight shifting, that does not mean necessarily catastrophic collapse. So, in order to plan for this, it’s very, very difficult. But the international community is looking very hard at ways in which we can bring people together to solve some of these monitoring issues.”
Data indicates that glaciers shrank between 2023 and 2025 with cumulative losses of 1,400 gigatonnes of water – or about one third of annual fresh water needs.
Every major glacier region on Earth lost ice for the fourth consecutive year.
“All 19 glacier regions around the globe lost ice; in Central Asia, Iceland, the Russian Arctic and western Canada and the United States, it was among the three worst years on record,” said Wayne Jenkinson, WMO’s Director of Hydrology and Cryosphere.
Some regions with smaller glaciers such as Central Europe, the Caucasus, the western Canada and the United States may already have reached “peak water”, Mr. Jenkinson warned.
“After this point, the glacier gives less meltwater each year simply because there is less ice left to melt. That matters for every community downstream that relies on water during hot, dry summers,” he explained.
Narelle van der Wel, WMO’s Head of Cryosphere Monitoring, Predictions and Services, stressed that while some further glacier loss is unavoidable, the eventual scale of the decline is not predetermined.
“Some glacier loss is inevitable, but total loss of glaciers is not yet inevitable,” she said, pointing to emissions reductions as central to limiting future losses.
Preparing for moving baselines
The report does not attribute every observed change to climate change alone. WMO says pressure on water resources and natural variability also contribute.
Mr. Jenkinson said governments need to prepare for “moving baselines” as historical patterns become less reliable.
“The situation 30 years ago is not where we are today,” he said. Countries, he added, need to prepare “for those changes that have really already arrived”.
ends
1
1
1
Edited News | OCHA , WHO
The deadly Ebola virus outbreak in DR Congo continues to spread across the vast country despite some success in containing it, aid officials said on Tuesday, in a renewed call for international support to help responders on the ground.
2
1
2
Press Conferences , Edited News | WFP
‘Super El Niño’ and converging crises worsen hunger in South Sudan and across the region - WFP
South Sudan’s hunger crisis is becoming increasingly catastrophic as violence, extreme weather and dwindling aid leave millions without enough food, the UN World Food Programme (WFP) warned on Tuesday.
1
1
1
Edited News | UN WOMEN
In war-torn Gaza, a growing number of women-headed households face “impossible decisions” every day, amid ongoing Israeli airstrikes and still-scarce resources, UN humanitarians said on Tuesday.
1
1
1
Edited News | OHCHR , UNOG
UN Human Rights Chief Volker Türk made the following remarks to the Enhanced Interactive Dialogue on the Independent Investigative Mechanism for Myanmar at the 63rd Human Rights Council.
1
Edited News | OHCHR , UNOG
UN Human Rights Chief Volker Türk today delivered an update on the global human rights situation to the 63rdsession of the Human Rights Council in Geneva.
1
1
1
Edited News | WHO
Repeated attacks on humanitarian warehouses put vital medical aid at risk in Ukraine - WHO
A new airstrike overnight damaged one of the main warehouses used by the UN health agency to store humanitarian medical supplies in the Kyiv region, the World Health Organization (WHO) said on Friday. This is the third attack to affect a WHO-used storage in the last three months.
2
2
2
Press Conferences , Edited News | WMO
Powerful El Niño heightens extreme-weather risks through 2027, as countries brace for impact - WMO
Fuelled by extraordinarily warm waters across the tropical Pacific Ocean, the El Niño climate pattern is expected to intensify in the coming months. Forecasters are almost certain that it will persist through February next year, with unusually warm conditions expected across the globe.
1
1
1
Edited News | OCHA , IFRC , UN WOMEN , WHO
Nepal flood deaths near 1,000 as those spared struggle to survive – UN humanitarians
With the death toll in Nepal’s catastrophic flash floods inching towards 1,000, rescue workers are facing harsh conditions while survivors lack access to food, safe water and health care, humanitarians said on Tuesday.